Globus Medical, Inc., a medical device company, develops and markets healthcare solutions for patients with musculoskeletal disorders. The company is headquartered in Audubon, Pennsylvania.
| Revenue (TTM) | $3.14B |
| Gross Profit (TTM) | $2.17B |
| EBITDA | $1.01B |
| Operating Margin | 24.80% |
| Return on Equity | 11.80% |
| Return on Assets | 8.74% |
| Revenue/Share (TTM) | $23.32 |
| Book Value | $35.52 |
| Price-to-Book | 2.08 |
| Price-to-Sales (TTM) | 3.18 |
| EV/Revenue | 3.004 |
| EV/EBITDA | 9.90 |
| Quarterly Earnings Growth (YoY) | -26.20% |
| Quarterly Revenue Growth (YoY) | 5.90% |
| Shares Outstanding | $111.83M |
| Float | $110.20M |
| % Insiders | 0.61% |
| % Institutions | 92.41% |
Volatility is currently contracting
Globus Medical (GMED) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
Robotics is poised for robust long-term growth. Consider NVDA, TER, ZBRA and GMED for potential market dominance across sectors.
Investors with an interest in Medical - Instruments stocks have likely encountered both Globus Medical (GMED) and Integer (ITGR). But which of these two companies is the best option for those looking for undervalued stocks?
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
RCMT, HCSG, BLMN, AGX and GMED have been added to the Zacks Rank #1 (Strong Buy) List on September 11, 2026.
GenAI offers growth potential for VCYT, GMED and UFPT, but regulatory and technology risks are likely to challenge adoption across healthcare.
Globus Medical, NetApp and Assurant stand out for sustainable sales growth, strong cash flow and favorable valuation and profitability screens.
BP, CRD.B, HCSG, TILE and GMED have been added to the Zacks Rank #1 (Strong Buy) List on September 9, 2026.
Excelsius3D™ – Intelligent 3-in-1 Imaging System Expands Excelsius™ Ecosystem in the European Union Excelsius3D™ – Intelligent 3-in-1 Imaging System Expands Excelsius™ Ecosystem in the European Union
Globus Medical (GMED) could produce exceptional returns because of its solid growth attributes.
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on GMED and any ticker you trade — then tracks every position and per-strategy win rate.
